We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Thermo Fisher webinar hosted by Technology Networks, being held on Sept 13th 2023

Unleash the Power of Genetics for Characterizing AAV Gene Therapies

Unleash the potential of genetic analysis technologies in gene therapy development. Join this webinar to explore the scientific advancements and breakthroughs made possible by analytical methods. Discover how these technologies overcome challenges, enabling critical product characterization, safety and regulatory compliance. 

Attendees will learn about the power of qPCR, dPCR, Sanger sequencing and fragment analysis, as well as how they complement each other in AAV gene therapy manufacturing. Don't miss this opportunity to gain valuable insights and optimize your gene therapies for successful clinical application.

Register now to dive into the world of genetic analysis and elevate your gene therapy development journey!

Attend this webinar to: 

  • Understand the pivotal role of analytical methods in gene therapy development
  • Explore how qPCR, dPCR, Sanger sequencing and fragment analysis support AAV gene therapy manufacturing
  • Gain insights into overcoming challenges in gene therapy development through the application of genetic analysis technologies
Keynote Speaker
Dr. Stephen Jackson
Dr. Stephen Jackson
Associate Director Applications, Thermo Fisher Scientific

Interested in sponsoring this webinar? Contact our friendly sales team here.
Now Available on Demand!
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar